ArticleBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2020

European Stakeholder Learnings Regarding Biosimilars: Part II-Improving Biosimilar Use in Clinical Practice.

Liese Barbier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.